[1]
E. Evelyn, P. B. Djohan, and F. Herawati, “Dupilumab Efficacy and Safety as an Add-On Therapy in Uncontrolled Asthma Patients: A Systematic Review”, JHS, vol. 15, no. 03, pp. 218–230, Nov. 2022.